ConductScience.org, home

Paper39725974

Spatiotemporal-controllable ROS-responsive camptothecin nano-bomb for chemo/photo/immunotherapy in triple-negative breast cancer.

Xu W and 11 others. J Nanobiotechnology, 2024. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Spatiotemporal-controllable ROS-responsive camptothecin nano-bomb for chemo/photo/immunotherapy in triple-negative breast cancer. Papers, record 39725974. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39725974

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Spatiotemporal-controllable ROS-responsive camptothecin nano-bomb for chemo/photo/immunotherapy in triple-negative breast cancer.
PubMed
Journal
J Nanobiotechnology
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
3.36, provisional
iCite
Revised in PubMed
2025-01-04
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xu WWenjie
2Zeng ZZhaokui
3Tang YYucheng
4Tian JJingjing
5Hao XXinyan
6Sun PPengcheng
7Peng YYanjin
8Tian TTian
9Xiang DDaxiong
10Wang RRongrong
11Chen CChuanpin
12Wu JJunyong

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Triple Negative Breast NeoplasmsMajor topic
CamptothecinMajor topic
Reactive Oxygen SpeciesMajor topic
ImmunotherapyMajor topic
PhototherapyMajor topic
NanoparticlesMajor topic
Animals
Female
Mice
Humans
Cell Line, Tumor
Hyaluronic Acid
Antineoplastic Agents
Mice, Inbred BALB C
Indoles
Mice, Nude

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82373295National Natural Science Foundation of ChinaPubMed
2024JJ4081Natural Science Foundation of Hunan ProvincePubMed
2023M733962China Postdoctoral Science FoundationPubMed
GZB20230873Postdoctoral Fellowship Program of CPSF, ChinaPubMed
QH20230269The Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South UniversityPubMed
2022XQLH103Joint Innovation Program for Postgraduates of Central South University and EnterprisesPubMed

Source PubMed

Download CSV of grants

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138280861In-situ-sprayed therapeutic hydrogel for oxygen-actuated Janus regulation of postsurgical tumor recurrence/metastasis and wound healing.Nat Commun2024https://conductscience.org/library/papers/38280861PubMed
228891273Self-Assembly of an Amphiphilic Janus Camptothecin-Floxuridine Conjugate into Liposome-Like Nanocapsules for More Efficacious Combination Chemotherapy in Cancer.Adv Mater2017https://conductscience.org/library/papers/28891273PubMed
328073672The long story of camptothecin: From traditional medicine to drugs.Bioorg Med Chem Lett2017https://conductscience.org/library/papers/28073672PubMed
435846843Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy.Bioact Mater2023https://conductscience.org/library/papers/35846843PubMed
534562837NIR-triggerable ROS-responsive cluster-bomb-like nanoplatform for enhanced tumor penetration, phototherapy efficiency and antitumor immunity.Biomaterials2021https://conductscience.org/library/papers/34562837PubMed
629666625Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy.Front Immunol2018https://conductscience.org/library/papers/29666625PubMed
725119147Development and evaluation of magnetic microemulsion: tool for targeted delivery of camptothecin to BALB/c mice-bearing breast cancer.J Drug Target2014https://conductscience.org/library/papers/25119147PubMed
829253923IR 780-loaded hyaluronic acid micelles for enhanced tumor-targeted photothermal therapy.Carbohydr Polym2018https://conductscience.org/library/papers/29253923PubMed
937323948Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.Int J Nanomedicine2023https://conductscience.org/library/papers/37323948PubMed
1038444205Three-in-One Peptide Prodrug with Targeting, Assembly and Release Properties for Overcoming Bacterium-Induced Drug Resistance and Potentiating Anti-Cancer Immune Response.Adv Mater2024https://conductscience.org/library/papers/38444205PubMed
1137992239Laser-Ignited Lipid Peroxidation Nanoamplifiers for Strengthening Tumor Photodynamic Therapy Through Aggravating Ferroptotic Propagation and Sustainable High Immunogenicity.Small2024https://conductscience.org/library/papers/37992239PubMed
1220568000Evaluation of temperature-sensitive, indocyanine green-encapsulating micelles for noninvasive near-infrared tumor imaging.Pharm Res2010https://conductscience.org/library/papers/20568000PubMed
1328135088Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria.J Med Chem2017https://conductscience.org/library/papers/28135088PubMed
1431188559High Co-loading Capacity and Stimuli-Responsive Release Based on Cascade Reaction of Self-Destructive Polymer for Improved Chemo-Photodynamic Therapy.ACS Nano2019https://conductscience.org/library/papers/31188559PubMed
1528165223Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.ACS Nano2017https://conductscience.org/library/papers/28165223PubMed
1610742577Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats.J Control Release2000https://conductscience.org/library/papers/10742577PubMed
1727785019GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.Int J Nanomedicine2016https://conductscience.org/library/papers/27785019PubMed
1834860505A Tumor-Targeting Near-Infrared Heptamethine Cyanine Photosensitizer with Twisted Molecular Structure for Enhanced Imaging-Guided Cancer Phototherapy.J Am Chem Soc2021https://conductscience.org/library/papers/34860505PubMed
1926322900Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes.ACS Appl Mater Interfaces2015https://conductscience.org/library/papers/26322900PubMed
2037914681Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity.Nat Commun2023https://conductscience.org/library/papers/37914681PubMed

See all 43 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42801248Advances in Drug Delivery Systems for Breast Cancer: From Microenvironment Barriers and Smart Carriers to Clinical Translation Strategies.Drug Des Devel Ther2026https://conductscience.org/library/papers/42801248PubMed
42696263Ethnobotany-guided exploration of plant-derived photosensitizer candidates for photodynamic therapy.Photochem Photobiol Sci2026https://conductscience.org/library/papers/42696263PubMed
42695488Reactive Oxygen Species in Breast Cancer: From Redox Dysregulation to ROS-Responsive Therapeutics.Cell Biochem Funct2026https://conductscience.org/library/papers/42695488PubMed
42514963TPGS Analog-Mediated Intracellular ROS-Amplifying Strategy Potentiates the In Vitro Anticancer Activity of a Dual-Thioketal-Linked Polymeric Drug Conjugate in A549 Lung Cancer Cells.Pharmaceutics2026https://conductscience.org/library/papers/42514963PubMed
42357328Advances in Camptothecin-Class Compounds Nanomedicines: A Comprehensive Review of Antitumor Strategies.Pharmaceutics2026https://conductscience.org/library/papers/42357328PubMed
42201430A Bibliometric Review and Knowledge Mapping of Microplastics and Nanoplastics in Cardiovascular Research.Cardiovasc Toxicol2026https://conductscience.org/library/papers/42201430PubMed
42075806Bioactive Natural Compounds in Triple-Negative Breast Cancer: Molecular Targets and Therapeutic Perspectives.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42075806PubMed
41731105Role of laser therapy in enhancing chemotherapy efficiency in breast cancer: low level laser therapy, photochemotherapy, and photodynamic therapy as promising treatments.Lasers Med Sci2026https://conductscience.org/library/papers/41731105PubMed
41660115Immediate tumor killing and long-term anti-tumor immunoreaction induced by Bufalin-loaded phototherapeutic Janus membrane in CRC postoperative therapy.Mater Today Bio2026https://conductscience.org/library/papers/41660115PubMed
41613221Nanobiotechnology-driven advances in sonodynamic therapy: unlocking the potential of sonosensitizers in clinical translation.RSC Adv2026https://conductscience.org/library/papers/41613221PubMed
41528374Camptothecin Nanoformulations: Recent Advances in Preparation, Bioactivities, and Clinical Perspectives.Ann Biomed Eng2026https://conductscience.org/library/papers/41528374PubMed
41168838Microbiome-targeted nanoplatforms and engineering approaches in breast cancer therapy.Mol Cancer2025https://conductscience.org/library/papers/41168838PubMed
41041069Hot-spot empowered gold nanoparticles for theranostics in breast cancer.Theranostics2025https://conductscience.org/library/papers/41041069PubMed
40863842Advancements in Tumor-Targeted Nanoparticles: Design Strategies and Multifunctional Therapeutic Approaches.Nanomaterials (Basel)2025https://conductscience.org/library/papers/40863842PubMed
40733095ROS-Responsive Nanoplatforms for Targeted Tumor Immunomodulation: A Paradigm Shift in Precision Cancer Immunotherapy.Pharmaceutics2025https://conductscience.org/library/papers/40733095PubMed
40725126Strategic Advances in Targeted Delivery Carriers for Therapeutic Cancer Vaccines.Int J Mol Sci2025https://conductscience.org/library/papers/40725126PubMed
40685358Application of photodynamic activation of prodrugs combined with phototherapy in tumor treatment.Mol Cancer2025https://conductscience.org/library/papers/40685358PubMed
40040956Biomimetic Atorvastatin Self-Assembled Nanomedicine Inhibits the Cyclooxygenase-2/Prostaglandin E2 Pathway Enhanced Photothermal and Antitumor Immunity.Biomater Res2025https://conductscience.org/library/papers/40040956PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39725974

GET https://conductscience.org/api/papers/v1/39725974/references?page=2